Fri, Dec 26, 2014, 6:48 AM EST - U.S. Markets open in 2 hrs 42 mins

Recent

% | $
Quotes you view appear here for quick access.

Theravance Inc. Message Board

  • profitize profitize May 13, 2013 7:04 PM Flag

    This is not a done deal

    nice two day profit. Elan's shareholders still need to approve the deal and from the sound on the IV message board there are many unhappy investors. As I always say a bird in the hand.......

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • On the face of it it is a great deal for THRX investors:

      At 21% of 15% of Breo sales, Elan will take home 3.15% of Breo sales. If Breo could hit $3 billion in sales, that's $94.5 million annually, not too shabby a return on its $1 billion investment. Of course, it'll take years to reach that level. The return in the initial few years is going to be paltry, and Elan really needs the other drugs to get approved to justify the investment.

      What many unhappy 'individual' or small institutional investors feel about this deal, it is irrelevant!

      What matters is that there is one gigantic institutional investor that has profited handsomely from this deal.

      And the gravy train keeps chugging along!

      Sentiment: Buy

 
THRX
14.55+0.22(+1.54%)Dec 24 1:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Novo Nordisk A/S
NYSEWed, Dec 24, 2014 2:48 PM EST
Yahoo! Inc.
NASDAQWed, Dec 24, 2014 12:59 PM EST